Vasodilatation induced by forskolin involves cyclic GMP production


Endothelium-derived relaxing factors contribute to smooth muscle relaxation. The aim of the present study was to investigate the contribution of nitric oxide (NO) produced in the endothelial cells to the vasodilatation stimulated with forskolin in rat aorta. Forskolin that directly activates adenylyl-cyclase, induced complete relaxation in phenylephrine-contracted aortas. Endothelium removal reduced the potency (pEC50) of forskolin without changes in the maximum effect (Emax). However, the inhibitor of endothelial NO-synthase (10 μM L- NG-Nitroarginine, L-NNA) reduced both Emax and pEC50 in intact endothelium aortic rings. L-NNA or L-NNA plus cyclooxygenase inhibitor indomethacin (10 μM) reduced both Emax and pEC50 of forskolin. Forskolin increased both the cytosolic Ca+2 concentration and the cytosolic NO concentration ([NO]c) in the endothelial cells. The PKA inhibitor KT5720 reduced the NO production activated by forskolin in the endothelial cells. The enhanced [NO]c in the endothelial cells increased cyclic guanosine-monophosphate (cGMP) in smooth muscle cells, which was abolished by L-NNA. Taken together, our results indicate that vasodilatation mediated by forskolin in rat aortic rings is potentiated by NO production in endothelial cells that increases the cGMP levels in the smooth muscle cells that along with cAMP contribute to the vasodilatation.

Share and Cite:

Neto, M. , Lunardi, C. , Rodrigues, G. and Bendhack, L. (2011) Vasodilatation induced by forskolin involves cyclic GMP production. Journal of Biophysical Chemistry, 2, 373-379. doi: 10.4236/jbpc.2011.24042.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Kukovetz, W.R., Poch, G. and Wurm, A. (1975) Quantitative relations between cyclic AMP and contraction as affected by stimulators of adenylate cyclase and inhibitors of phosphodiesterase. Advances in Cyclic Nucleotide Research, 5, 395-414.
[2] Seamon, K.B. and Daly, J.W. (1981) Forskolin: A unique diterpene activator of cyclic AMP-generating systems. Proceedings of the National Academy of Sciences of the United States of America, 78, 3363-3367. doi:10.1073/pnas.78.6.3363
[3] Laurenza, A., Khandelwal, Y., De Souza, N.J., Rupp, R.H., Metzqer, H. and Seamon, K.B. (1987) Stimulation of adenylate cyclase by water-soluble analogues of forskolin. Molecular Pharmacology, 32, 133-139.
[4] Muller, M.J. and Baer, H.P. (1983) Relaxant effects of forskolin in smooth muscle. Role of cyclic AMP. Naunyn- Schmiedeberg’s Archives of Pharmacology, 322, 78-82. doi:10.1007/BF00649356
[5] Manolopoulos, V.G., Pipili-Synetos, E., Den Hertog, A. and Nelemans, A. (1991) Inositol phosphates formed in rat aorta after alpha 1-adrenoceptor stimulation are inhibited by forskolin. European Journal of Pharmacology, 207, 29-36. doi:10.1016/S0922-4106(05)80034-3
[6] Meisheri, K.D. and van Breemen, C. (1982) Effects of beta-adrenergic stimulation on calcium movements in rabbit aortic smooth muscle: Relationship with cyclic AMP. The Journal of Physiology, 331, 429-441.
[7] Bhalla, R.C., Webb, R.C., Singh, D. and Brock, T. (1978) Role of cyclic AMP in rat aortic microsomal phosphory- lation and calcium uptake. American Journal of Physiology, 234, H508-H514.
[8] Conti, M.A. and Adelstein, R.S. (1981) The relationship between calmodulin binding and phosphorylation of smooth muscle myosin kinase by the catalytic subunit of 3':5' cAMP-dependent protein kinase. The Journal of Biological Chemistry, 256, 3178-3181.
[9] Scheid, C.R. and Fay, F.S. (1984) Beta-adrenergic effects on transmembrane 45Ca fluxes in isolated smooth muscle cells. American Journal of Physiology, 246, C431-C438.
[10] Moncada, S., Palmer, R.M. and Higgs, E.A. (1991) Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacological Reviews, 43, 109-142.
[11] Lowenstein, C.J. and Snyder, S.H. (1992) Nitric oxide, a novel biologic messenger. Cell, 70, 705-707. doi:10.1016/0092-8674(92)90301-R
[12] Boo, Y.C., Sorescu, G.P., Bauer, P.M., Fulton, D., Kemp, B.E., Harrison, D.G., Sessa, W.C. and Jo, H. (2003) Endothelial NO synthase phosphorylated at ser635 produces NO without requiring intracellular calcium increase. Free Radical Biology & Medicine, 35, 729-741. doi:10.1016/S0891-5849(03)00397-6
[13] Moncada, S.and Vane, J.R. (1979) The role of prostacy- clin in vascular tissue. Desty’s Federal Procedure, 38, 66-71.
[14] Samokovlisky, A., Rimon, G. and Danon, A. (1999) Differential regulation of cyclooxygenase isoenzymes by cAMP-elevating agents. European Journal of Pharmacology, 378, 203-211. doi:10.1016/S0014-2999(99)00461-6
[15] Dias, K.L., Correia, N.A., Pereira, K.K., Barbosa-Filho, J.M., Cavalcante, K.V., Araújo, I.G., Silva, D.F., Guedes, D.N., Neto, M.A., Bendhack, L.M. and Medeiros, I.A. (2007) Mechanisms involved in the vasodilator effect induced by diosgenin in rat superior mesenteric artery. European Journal of Pharmacology, 574, 172-178. doi:10.1016/j.ejphar.2007.07.017
[16] Kojima, H., Nakatsubo, N., Kikuchi, K., Kawahara, S., Kirino, Y., Nagoshi, H., Hirata, Y. and Nagano, T. (1998) Detection and imaging of nitric oxide with novel fluores- cent indicators: Diaminofluoresceins. Analytical Chemistry, 70, 2446-2453. doi:10.1021/ac9801723
[17] Rodrigues, G.J., Lunardi, C.N., Lima, R.G., Santos, C.X., Laurindo, F.R.M., Silva, R.S. and Bendhack, L.M. (2008) Vitamin C improves the effect of a new nitric oxide donor on the vascular smooth muscle from renal hypertensive rats. Nitric Oxide, 18, 176-183. doi:10.1016/j.niox.2007.12.002
[18] Murray, K.J. (1990) Cyclic AMP and mechanism of vasodilatation. Pharmacology & Therapeutics, 47, 329- 345.doi:10.1016/0163-7258(90)90060-F
[19] McCall, T.B., Feelisch, M., Palmer, R.M. and Moncada, S. (1991) Identification of N-iminoethyl-L-ornithine as an irreversible inhibitor of nitric oxide synthase in phago- cytic cells. European Journal of Pharmacology, 102, 234 -238.
[20] Koide, M., Kawahara, Y., Nakayama, I., Tsuda, T. and Yokohama, M. (1993) Cyclic AMP-elevating agents induce an inducible type of nitric oxide synthase in cultured vascular smooth muscle cells. Synergism with the induction elicited by inflammatory cytokines. The Journal of Biological Chemistry, 268, 24959-24966.
[21] Imai, T., Hirata, Y., Kanno, K. and Marumo, F. (1994) Induction of nitric oxide synthase by cyclic AMP in rat vascular smooth muscle cells. The Journal of Clinical Investigation, 93, 543-549. doi:10.1172/JCI117005
[22] Nakayama, I., Kawahara, Y., Tsuda, T., Koide, M. and Yokohama, M. (1995) Cyclic AMP elevating agents synergize with inflammatory cytokines to induce an inducible type of nitric oxide synthase in cultured vascular smooth muscle cells. Annals of the New York Academy of Sciences, 748, 586-589. doi:10.1111/j.1749-6632.1994.tb17366.x
[23] Ikeda, U., Kanbe, T. and Shimada, K. (1996) Adrenome- dullin increases inducible Nitric oxide synthase in rat vascular smooth muscle cells stimulated with interleukin- 1. Hypertension, 27, 1240-1244.
[24] Berkels, R., Dachs, C., Roesen, R. and Klaus, W. (2000) Simultaneous measurement of intracellular Ca2+ and ni- tric oxide: A new method. Cell Calcium, 27, 281-286. doi:10.1054/ceca.2000.0119
[25] Stevens, T., Fouty, B., Hepler, L., Richardson, D., Brough, G., McMurtry, I.F. and Rodman, D.R. (1997) Cytosolic Ca2+ and adenylyl cyclase responses in phenotypically distinct pulmonary endothelial cells. Lung Physiology, 272, L51-L59.
[26] Manolopaulos, V.G., Liu, J., Unsworth, B.R. and Lelkes, P.I. (1995) Adenylyl cyclase isoforms are differentially expressed in primary cultures of endothelial cells and wh- ole tissue homogenates from various rat tissues. Bioche- mical and Biophysical Research Communications, 208, 323-331. doi:10.1006/bbrc.1995.1341
[27] Chen, Z.P., Mitchelhill, K.I., Michell, B.J., Stapleton, D., Rodriguez-Crespo, I., Witters, L.A., Power, D.A., Ortiz de Montellano, P.R. and Kemp, B.E. (1999) AMP-activated protein kinase phosphorylation of endothelial NO synthase. FEBS Letters, 443, 285-289. doi:10.1016/S0014-5793(98)01705-0
[28] Hashimoto, A., Miyakoda, G., Hirose, Y. and Mori, T. (2006) Activation of endothelial nitric oxide synthase by cilostazol via a cAMP/protein kinase A- and phosphatidy- linositol 3-kinase/Akt-dependent mechanism. Athero- sclerosis, 189, 350-357. doi:10.1016/j.atherosclerosis.2006.01.022
[29] Bredt, D.S. and Snyder, S.H. (1990) Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proceedings of the National Academy of Sciences of the United States of America, 87, 682-685. doi:10.1073/pnas.87.2.682
[30] Govers, R. and Rabelink, T.J. (2001) Cellular regulation of endothelial nitric oxide synthase. American Journal of Physiology Renal Physiology, 280, F193-F206.
[31] Michel, T., Li, G.K. and Busconi, L. (1993) Perspective series: Nitric oxide and nitric oxide synthases-nitric oxide synthases: Which, where, how and why? Proceedings of the National Academy of Sciences of the United States of America, 90, 6252-6256. doi:10.1073/pnas.90.13.6252

Copyright © 2021 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.